Antihistamines are a class of drugs that inhibit the action of histamine by attacking the specific cell receptors meant for histamines. Histamine is an immune substance released by body’s immune system upon attack by allergens or due to intake of histamine-deficient food, some food items also trigger their excessive production which creates immune response. Histamine attaches to specific receptors of body cells which results in symptoms such as running nose, watery eyes, pain, itching, redness, and wheezing. Antihistamines are used to relieve the symptoms of seasonal allergies, motion sickness, nausea, cold and cough, anxiety. They are also used to treat skin allergies such as urticarial. Besides being used for seasonal allergies, antihistamines are administered in case of chronic allergies or other recurring conditions.
Changing lifestyle and rise in environmental pollution are projected to increase the number of patients affected with seasonal allergies. According to the World Health Organization’s “White Book on Allergy 2011-2012”, allergic rhinitis affected 10% to 30% of the world population, while lifetime prevalence of urticarial worldwide was above 20%. High prevalence of allergies and increase in incidences among children are projected to augment the intake of antihistamines during the forecast period. Antihistamines are inexpensive and some of them are also available as an over-the-counter medicine. They are preferred as the initial line of treatment for various allergies such as hay fever as they offer quick relief and have low side-effects. These factors are projected to drive the expansion of the global antihistamines market. However, most of these drugs are off-patent and have attracted several small and large-scale generic players, thereby resulting in intense price competition and devaluation of the market.
The global antihistamines market can be segmented based on dosage form, access, distribution channel, and region. In terms of dosage form, the global antihistamines market can be divided into tablets & capsules, liquids, injectable, nasal sprays, and eye drops. The tablets & capsules segment is projected to account for the dominant share of global antihistamines market owing to their low cost, ease of administration, and convenience in storage. In terms of access, the global antihistamines market can be classified into prescription-based and over-the-counter (OTC) antihistamines. Major companies are striving to switch their antihistamines drugs from prescription-based to over-the-counter availability, which is estimated to boost the growth of the OTC segment. Based on distribution channel, the global antihistamines market can be segregated into hospital pharmacies, retail pharmacies, drug stores, and online pharmacies. The retail pharmacies segment is anticipated to account for a prominent share in the global antihistamine market during the forecast period.
Geographically, the global antihistamines market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is estimated to constitute a prominent share of the global market during the forecast period, owing to high price of antihistamines in this region and also rise in the trend of self-medication. Moreover, high prevalence of allergic conditions in this region is estimated to propel the antihistamines market. Europe is anticipated to account for a significant share of the global market during the forecast period. According to the European Academy of Allergy and Clinical Immunology, around 100 million people in Europe suffer from allergic rhinitis. Increase in health care expenditure in Asia Pacific is projected to fuel the expansion of the antihistamines market during the forecast period.
Major players operating in the global antihistamines market are Bayer AG, Almirall S.A., Meda Consumer Healthcare Inc., AstraZeneca AB, Johnson & Johnson, Novartis AG, Sanofi SA, Pfizer, Inc., Boehringer Ingelheim GmbH, Akorn, Inc., Merck & Co., Inc., Teva Pharmaceutical Industries Ltd. and others.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.